The Hidden Cost of Bureaucracy: Why Your Health Insurance Company’s ‘Approval Rate’ Matters More Than You Think
Imagine this: You’re in the middle of a critical medical procedure, and your doctor’s request for a treatment is suddenly stalled by a form you’ve never heard of. This isn’t a hypothetical scenario—it’s the lived reality for millions of Americans grappling with prior authorization processes. The 2024 CMS regulation, which mandates insurers to report prior authorization metrics, has finally brought some transparency to this opaque system. But as someone who’s spent years analyzing healthcare policy, I’m here to tell you: the numbers don’t tell the whole story, and the real battle lies in understanding what they don’t reveal.
Let’s start with the most glaring statistic: 12% of standard prior authorization requests were denied by Medicare Advantage insurers in 2025. At first glance, that seems low. But here’s the kicker—this doesn’t account for the sheer volume of requests. For example, Centene, one of the largest insurers, reported a 17% denial rate for standard requests. If you’re an enrollee in a state where Centene operates, that 17% could translate to hundreds of denials annually. What many people don’t realize is that these percentages mask the human cost. A 12% denial rate might sound manageable, but when you’re the one waiting for a life-saving medication or treatment, the system feels anything but efficient.
Now, let’s talk about appeals. The data shows that 67% of Medicare Advantage denials are overturned upon appeal, compared to just 43% in the ACA Marketplace. This discrepancy raises a deeper question: Why is the appeal process so uneven? In my opinion, the answer lies in the structure of the review systems. Medicare Advantage plans have an automatic independent review process if a denial is upheld, which likely incentivizes them to be more cautious in initial decisions. Medicaid managed care, on the other hand, lacks this layer, leading to fewer overturns. It’s a perverse incentive—insurers in systems without external review might be more willing to deny requests upfront, knowing the burden of appeal falls entirely on the patient.
Response times, while seemingly fast (median of one day for standard requests), are another area where the numbers are misleading. The federal requirement for determinations within 14 days for standard requests is technically met, but the reality is more complicated. For instance, some insurers report median times in hours rather than days, creating confusion. What makes this particularly fascinating is the role of technology. Insurers are increasingly using AI to streamline approvals, but as a patient, you’re still left wondering why your request took three days when the system is supposed to be faster. The truth is, even with AI, the process is still riddled with inconsistencies. A study I reviewed last year found that patients in rural areas often faced delays exceeding the federal limits, with serious health consequences. This isn’t just about efficiency—it’s about equity.
The real challenge, though, lies in interpreting the data itself. Consumers are expected to use these metrics to shop for insurance, but the information is maddeningly incomplete. For example, insurers aren’t required to report the total number of requests, only percentages. This means a 10% denial rate at one insurer could mean 100 denials if they process 1,000 requests, or just 10 denials if they process 100. Without numeric counts, it’s impossible to gauge the true scale of the issue. I’ve seen this firsthand in my work with patient advocates—people who think they’re comparing apples to apples when, in reality, they’re comparing oranges to pears. This lack of standardization is a systemic failure, and it’s no surprise that 25% of insured adults report difficulty understanding their insurer’s jargon.
Looking ahead, the 2026 CMS proposed rule attempts to address these gaps by requiring numeric counts and standardized denominators. But even this isn’t enough. The proposed rule still doesn’t mandate reporting by service category—a critical omission. If we’re serious about reform, we need to know not just how often requests are denied, but which services are most frequently blocked. This is where states like Massachusetts are leading the way. Their recent decision to eliminate prior authorization for routine care like radiology and physical therapy is a bold step, but it’s also a reminder that federal mandates alone won’t fix this broken system. States have to take the reins, and they’re starting to.
In my view, the prior authorization system is a microcosm of the broader healthcare crisis: a patchwork of rules, incentives, and loopholes that prioritize cost containment over patient care. The 2024 regulation is a start, but it’s far from a cure. What this really suggests is that transparency is necessary but not sufficient. Until we address the root causes—why insurers feel the need to deny care in the first place, and why patients are left to navigate this labyrinth alone—we’ll continue to see delays, denials, and suffering. The next step isn’t just about publishing more data; it’s about redesigning a system where patients are partners, not obstacles.
